Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 4:19 pm Purchase | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners II L.P. | 2,270,072 8.2% | 1,601,632 (+239.61%) | View |
| 2022-02-14 4:18 pm Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 2,880,096 7.8% | 291,155 (+11.25%) | View |
| 2022-02-14 4:17 pm Sale | 13G | ATYR PHARMA INC LIFE | Venrock Healthcare Capital Partners II L.P. | 1,565,000 5.6% | -250,000 (-13.77%) | View |
| 2022-02-14 4:15 pm Sale | 13G | CORVUS PHARMACEUTICALS INC CRVS | Venrock Healthcare Capital Partners II L.P. | 250,000 0.5% | -3,177,461 (-92.71%) | View |
| 2022-02-14 4:14 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | Venrock Healthcare Capital Partners II L.P. | 4,302,126 9.99% | 4,302,126 (New Position) | View |
| 2022-02-14 4:14 pm Sale | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II L.P. | 1,000,000 2.7% | -691,623 (-40.89%) | View |
| 2022-02-14 4:13 pm Purchase | 13G | ACLARIS THERAPEUTICS INC ACRS | Venrock Healthcare Capital Partners II L.P. | 4,563,962 7.5% | 4,563,962 (New Position) | View |
| 2022-02-14 4:13 pm Purchase | 13G | AADI BIOSCIENCE INC AADI | Venrock Healthcare Capital Partners II L.P. | 1,529,402 7.3% | 1,529,402 (New Position) | View |
| 2021-11-10 4:05 pm Purchase | 13G | LIANBIO SPONSORED ADS LIAN | Venrock Healthcare Capital Partners II L.P. | 5,378,341 5.1% | 5,378,341 (New Position) | View |
| 2021-09-30 4:05 pm Purchase | 13G | CORVUS PHARMACEUTICALS INC CRVS | Venrock Healthcare Capital Partners II L.P. | 3,427,461 8.1% | 3,427,461 (New Position) | View |
| 2021-09-27 5:14 pm Purchase | 13G | ATYR PHARMA INC LIFE | Venrock Healthcare Capital Partners II L.P. | 1,815,000 6.7% | 1,815,000 (New Position) | View |
| 2021-06-07 4:30 pm Purchase | 13G | PROVENTION BIO INC PRVB | Venrock Healthcare Capital Partners II L.P. | 3,843,796 6.1% | 3,843,796 (New Position) | View |
| 2021-04-15 4:09 pm Purchase | 13G | INSTIL BIO INC TIL | Venrock Healthcare Capital Partners II L.P. | 6,865,076 5.4% | 6,865,076 (New Position) | View |
| 2021-03-01 4:07 pm Sale | 13G | ALTIMMUNE INC ALT | Venrock Healthcare Capital Partners II L.P. | 3,622,964 9.99% | -877,036 (-19.49%) | View |
| 2021-02-16 4:11 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | Venrock Healthcare Capital Partners II L.P. | 14,240,237 9.99% | 14,240,237 (New Position) | View |
| 2021-02-16 4:10 pm Sale | 13G | SURFACE ONCOLOGY INC SURF | Venrock Healthcare Capital Partners II L.P. | 1,442,895 3.5% | -2,435,000 (-62.79%) | View |
| 2021-02-16 4:10 pm Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | Venrock Healthcare Capital Partners II L.P. | 668,440 4.1% | -214,374 (-24.28%) | View |
| 2021-02-16 4:09 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Venrock Healthcare Capital Partners II L.P. | 2,588,941 7.3% | -3,913,899 (-60.19%) | View |
| 2021-02-16 4:06 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II L.P. | 1,691,623 5.2% | 34,000 (+2.05%) | View |
| 2020-11-16 4:05 pm Purchase | 13G | ATHIRA PHARMA INC ATHA | Venrock Healthcare Capital Partners II L.P. | 1,657,623 5.1% | 1,657,623 (New Position) | View |